Stefano Buono

Director at Abeona Therapeutics LLC

Stefano Buono

Stefano Buono

Director at Abeona Therapeutics LLC

Overview
Career Highlights

Advanced Accelerator Applications SA

RelSci Relationships

184

Number of Boards

3

Birthday

1967

Age

54

Relationships
RelSci Relationships are individuals Stefano Buono likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Tre A SRL

Relationship likelihood: Strong

Former Chief Operating Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

General Manager Region Europe Oncology at Novartis Venture Fund

Relationship likelihood: Strong

Founder at Kapital Consulting LLC

Relationship likelihood: Strong

President of Novartis Pharmaceuticals at Novartis AG

Relationship likelihood: Strong

Chairman & President at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Head of Research & Business Development at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Director at Nogra Pharma Ltd.

Relationship likelihood: Strong

Former Management Consultant at Accenture Plc

Relationship likelihood: Strong

Head of Strategy & Operational Planning at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Paths to Stefano Buono
Potential Connections via
Relationship Science
You
Stefano Buono
Director at Abeona Therapeutics LLC
Education
Class of 1991

The University of Turin is a public research university in the city of Turin in the Piedmont region of north-western Italy. Founded in 1404, it is one of the oldest universities in Europe.

Career History
Director
Tenure Unconfirmed

Abeona Therapeutics LLC engages in developing and delivering gene therapy products for severe and life-threatening rare diseases. It focuses on treatments for patients with Sanfilippo syndrome Type A and Type B. It has an exclusive license through Nationwide Children’s Hospital to the ABO-101 and ABO-102 patent portfolios. The company was founded on March 29, 2013 and is headquartered in Cleveland, OH.

Founder
2002 - 2018

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Saint Genis Pouilly, France.

Physicist
Prior

Established in 1990, CRS4 (Center for Advanced Studies, Research and Development in Sardinia) is located within Science and Technology Park (Polaris), a point of attraction for high-tech research 40 km from Cagliari. CRS4 is an interdisciplinary research center promoting the study, development and application of innovative solutions to problems stemming from natural, social and industrial environments. Information Society and Technology and High Performance Computing are the supporting foundations. The main objective is innovation. The mission is to help Sardinia to build and support a layer of modern high tech industries considered essential to its economic and cultural development.

Investments
Details Hidden

Kither Biotech Srl is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on the treatment of chronic inflammatory diseases. The company was founded by Emilio Hirsch, Marco Kevin Malisani, and Alberto Bardelli and is headquartered in Turin, Italy.

Details Hidden

Planet Holding Ltd. invests in companies that provides smart solutions in the areas of built environment, technological systems, ecosystem resources, and society. The company was founded by Susanna Marchionni and Giovanni Savio and is headquartered in London, the United Kingdom.

Details Hidden

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Saint Genis Pouilly, France.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stefano Buono. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stefano Buono's profile does not indicate a business or promotional relationship of any kind between RelSci and Stefano Buono.